News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerulean Pharma Inc. (CERU) Announces CRLX101 Combination Data At 2014 American Society of Clinical Oncology Annual Meeting


6/3/2014 9:00:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO, June 3, 2014 (GLOBE NEWSWIRE) -- ASCO Annual Meeting: Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, announced today that three abstracts on its lead candidate, CRLX101, were included in the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 30 through June 3.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES